(AOF) – Mauna Kea Technologies announced a 74% increase in its revenues over the first 9 months of 2023. A solid performance for the inventor of Cellvizio, the multidisciplinary platform for confocal laser endomicroscopy by probe and by needle, enabled thanks to partnership revenues and growth in the United States (+40%).
“This third quarter was once again positive after a solid second quarter, a performance which reflects our commercial and business development dynamics. Indeed, the Group benefited from its partnership strategy, which generated more than 30% of the turnover. business, and we continue to see exciting opportunities to increase the number of partners marketing Cellvizio,” said Mauna Kea Technologies management.
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
